The government has decided to stick to the new market-based formula for essential drugs.
Pharma promoters are clearly upping the ante against the Supreme Court order, which last week asked the government not to…
If the Supreme Court’s order of last week on drug pricing policy prevails, availability of essential drugs in the country…
The most sophisticated drug regulators of the world ? like the Food and Drug Administration of the US ? are…
Glaxosmithkline, Ranbaxy Labs and Cipla are likely to be hit the worst due to the new drug pricing policy proposed…
A new statutory technical expert body on medical devices, on the lines of Drug Technical Advisory Board, has said that…
A final formula to keep prices of essential medicines under check eluded the Sharad Pawar-headed group of ministers on drug…
The Prime Minister may soon summon a meeting of the finance, commerce, health and chemicals and fertiliser ministries to draw…
The Drug Controller General of India’s office may soon get a new name and a broader mandate to include drug…
The International Cri-minal Police Organisation, popularly known as Interpol, wants to assist the Indian government in its effort to clamp…
The government is planning to tighten the regulatory landscape of the R4,500-crore vitamins and neutraceuticals market in the country.
Mylan, the second-largest US generic drug firm with annual sales of over $6 billion, is in late-stage talks with the…
Buying popular abortion pills ? Mifepristone and Misoprostol ? from your neighbourhood pharmacy may no longer be possible as the…
The Bangalore-based Manipal Hospitals, among top five corporate hospital chains in India with 1,600 beds in Karnataka, Tamil Nadu, Andhra…
Pharma companies marketing ?new drugs? would now have to submit periodic safety profiles of these products to the Drug Controller…
Erratic monsoon, notorious for harassing farmers, is causing differences in unexpected quarters.
Multinational pharmaceutical firms keen to buy into existing domestic drug firms would have to take clearance from the Foreign Investment…
Graham Lewis, vice-president Europe, global pharma strategy, IMS Health, in an interview to Soma Das, underlines the changing global dynamics…
